CanBas Co (TSE:4575) EBITDA Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4575 CanBas Co Ltd TSE:4575
31 GF Score
Price 円796.00
View Full Analysis

What is CanBas Co EBITDA Margin %?

CanBas Co TSE:4575 +5.99% 31 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:4575 with a GF Score™ of 31/100. Among 939 Biotechnology companies, CanBas Co ranks worse than 106496.17% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. CanBas Co's EBITDA for the three months ended in Dec. 2025 was 円0.00 Mil. CanBas Co's Revenue for the three months ended in Dec. 2025 was 円0.00 Mil. Therefore, CanBas Co's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

CanBas Co  (TSE:4575) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

CanBas Co EBITDA Margin % Related Terms

CanBas Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for CanBas Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CanBas Co EBITDA Margin % Chart

CanBas Co Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -479.40 0.00 0.00 0.00 0.00

CanBas Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSE:4575 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, CanBas Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanBas Co EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CanBas Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where CanBas Co's EBITDA Margin % falls into.


TSE:4575
31GF Score
CanBas Co Ltd TSE:4575
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CanBas Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

CanBas Co's EBITDA Margin % for the fiscal year that ended in Jun. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-1109.562/0
= %

CanBas Co's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
CanBas Co (TSE:4575) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CanBas Co and its competitors. According to the industry distribution chart, CanBas Co ranks #999999 out of 939 companies in the Biotechnology industry.
Is CanBas Co's EBITDA Margin % too high?
CanBas Co's current EBITDA Margin % is 0.00%. Based on the distribution chart, CanBas Co ranks #999999 out of 939 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CanBas Co has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does CanBas Co's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CanBas Co ranks #999999 out of 939 companies for EBITDA Margin %. This places CanBas Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CanBas Co and its competitors. CanBas Co's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanBas Co stock overvalued right now?
CanBas Co (TSE:4575) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. CanBas Co's overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For CanBas Co (TSE:4575), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CanBas Co Business Description

Address 2-2-1 Otemachi, Numazu, Shizuoka, JPN, 410-0891
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.
31GF Score

Get the complete analysis for TSE:4575

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円796.00
Price